James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), sold 14,335 shares at $100.29 ($1.2M) on 2019-03-05, disclosed to the SEC on 2019-03-07.
Open-market sale of $1.2M RETA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,631 | $0 | 0.0% |
| 2 | $100.29 | 5,852 | $587K | 50.0% |
| 3 | $100.29 | 5,852 | $587K | 50.0% |
| Total | $81.88 avg | 14,335 | $1.2M | 100% |
| Filing → |
| RETA | BUY | 2018-07-26 | $139K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |
| RETA | BUY | 2017-08-01 | $250K | — | Filing → |